BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14595390)

  • 1. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation.
    Yang H; Acker JP; Cabuhat M; McGann LE
    Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.
    Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE
    Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of different cooling rates on cryopreservation of hematopoietic stem cells from cord blood].
    Shen HP; Ding CM; Chi ZY; Kang ZZ; Tan WS
    Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):489-92. PubMed ID: 15969071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
    Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
    Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing cord blood viability assessment before cryopreservation.
    Solomon M; Wofford J; Johnson C; Regan D; Creer MH
    Transfusion; 2010 Apr; 50(4):820-30. PubMed ID: 19919556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
    Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
    Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for Cryobiology and Biology of Bone Marrow Transplantation (CBTMO), Spain.
    Perez-Oteyza J; Bornstein R; Corral M; Hermosa V; Alegre A; Torrabadella M; Ramos P; Garcia J; Odriozola J; Navarro JL
    Haematologica; 1998 Nov; 83(11):1001-5. PubMed ID: 9864921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration.
    Jansen J; Nolan PL; Reeves MI; Akard LP; Thompson JM; Dugan MJ; Hanks SG
    Cytotherapy; 2009; 11(1):79-85. PubMed ID: 19153854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.
    Kurtz J; Seetharaman S; Greco N; Moroff G
    Transfusion; 2007 Sep; 47(9):1578-87. PubMed ID: 17725720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.
    Yoo KH; Lee SH; Kim HJ; Sung KW; Jung HL; Cho EJ; Park HK; Kim HA; Koo HH
    Bone Marrow Transplant; 2007 May; 39(9):515-21. PubMed ID: 17334379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations.
    Foïs E; Desmartin M; Benhamida S; Xavier F; Vanneaux V; Rea D; Fermand JP; Arnulf B; Mounier N; Ertault M; Lotz JP; Galicier L; Raffoux E; Benbunan M; Marolleau JP; Larghero J
    Bone Marrow Transplant; 2007 Nov; 40(9):831-5. PubMed ID: 17724443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants.
    Schuurhuis GJ; Muijen MM; Oberink JW; de Boer F; Ossenkoppele GJ; Broxterman HJ
    Bone Marrow Transplant; 2001 Mar; 27(5):487-98. PubMed ID: 11313682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage characteristics of cord blood progenitor cells: report of a multicenter study by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
    Pamphilon D; Curnow E; Belfield H; Reems JA; McMannis J; Lecchi L; Szczepiorkowski Z; McKenna D
    Transfusion; 2011 Jun; 51(6):1284-90. PubMed ID: 21133927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
    Rodríguez L; Velasco B; García J; Martín-Henao GA
    Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.